ELI LILLY H9B-MC-BCDX

By June 19, 2019 Closed

“A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Subcutaneous LY2127399 in Patients with Systemic Lupus Erythematosus (SLE) (ILLUMINATE-X)”

Join the discussion 5 Comments

Leave a Reply